Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its previously announced ...
Indivior Pharmaceuticals (INDV) has announced the pricing of its offering of $450M in convertible senior notes due in 2031. The offering size was increased from an initial amount of $400M.
CRISPR Therapeutics AG (Nasdaq: CRSP) (the “Company”) today announced the pricing of $550 million aggregate principal amount ...
1d
PAR Technology Corporation Announces Proposed Offering of $225.0 Million of Convertible Senior Notes
PAR Technology Corporation (NYSE: PAR) ("PAR" or the "Company") announced today its intention to offer $225.0 million ...
PAR Technology (PAR) has priced a private offering of $250M aggregate principal amount of 4.00% Convertible Senior Notes due 2031. The company also granted to the initial purchasers of the notes a ...
Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced its intention to offer, subject to market and other conditions, $400,000,000 aggregate principal amount of convertible senior notes due ...
PAR Technology Corporation (NYSE:PAR) shares fell 10.4% Friday after the company priced a private offering of $250.0 million in 4.00% Convertible Senior Notes due ...
CRISPR Therapeutics (CRSP) upsized a $550M convertible notes deal due 2031 at 1.125%, with a 45% conversion premium—get the key terms now.
Shares of PAR Technology fell after the company priced a private offering of $250 million of 4% convertible senior notes due 2031. The stock fell 20% to $12.63 in premarket trading. It was down 73% ...
Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) shares fell 8% after the company announced its intention to offer $400 million in convertible senior notes due 2031 in a private placement to qualified ...
CRISPR Therapeutics AG (NASDAQ:CRSP) shares fell 6.75% Tuesday following the company’s announcement of a proposed $350 million convertible senior notes offering. The gene-editing company said it ...
IREN Closes $2.3 Billion Convertible Notes Offering and the Repurchase of Existing Convertible Notes
$1.0 billion offering of 0.25% convertible senior notes due 2032 $1.0 billion offering of 1.00% convertible senior notes due 2033 $300 million greenshoe fully exercised Capped call transactions ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results